Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation

被引:20
|
作者
Selimovic, Nedim [1 ]
Andersson, Bert [1 ]
Bergh, Claes-Hakan [1 ]
Martensson, Gunnar [2 ]
Nilsson, Folke [3 ]
Bech-Hanssen, Odd [4 ]
Rundqvist, Bengt [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Cardiol, SE-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Resp Med, SE-41345 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Thorac Surg, SE-41345 Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Dept Clin Physiol, SE-41345 Gothenburg, Sweden
关键词
lung function tests; lung transplantation; mortality on the waiting list; pulmonary hypertension; pulmonary vascular resistance;
D O I
10.1111/j.1432-2277.2007.00605.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lung transplantation (LTx) is a therapeutic option for patients with end-stage lung disease. However, the mortality rate of patients on the waiting list is high. The purpose of this study was to examine the prognostic value of cardio-pulmonary hemodynamics for death in patients awaiting LTx. Retrospectively, 177 patients with advanced lung disease accepted for LTx at Sahlgrenska University Hospital from January 1990 through December 2003 were studied. Patient demographics, pulmonary function tests, gas exchange and hemodynamic variables were included in the analysis. Death while awaiting LTx was the primary endpoint for all analyses. Mean age was 49 9 years. Main diagnoses were alpha 1 antitrypsin deficiency (n = 56), chronic obstructive pulmonary disease (n = 61), cystic fibrosis (n = 14) and interstitial lung disease (n = 46). Thirty patients died (17%). LTx was performed in 143 cases. By univariate analyses, forced vital capacity (FVC) % of predicted, pulmonary vascular resistance (PVR) and diagnosis were associated with risk for death. In multivariate analysis PVR (HR, 1.22; 95% Cl, 1.06-1.41; P = 0.006) and FVC% of predicted (HR, 0.97; 95% CI, 0.94-0.99; P = 0.01) were independently associated with death. Patients with increased PVR and a lower FVC % of predicted awaiting LTx should be considered for a higher organ allocation priority. Assessment of pulmonary hemodynamics needs to be considered during evaluation for LTx.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 50 条
  • [41] Lung Transplantation for Interstitial Lung Diseases and Pulmonary Hypertension
    Gottlieb, Jens
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (03) : 281 - 287
  • [42] Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation
    Nathan, Steven D.
    Shlobin, Oksana A.
    Ahmad, Shahzad
    Burton, Nelson A.
    Barnett, Scott D.
    Edwards, Erik
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (10) : 1165 - 1171
  • [43] LUNG TRANSPLANTATION FOR PULMONARY-HYPERTENSION
    HAVERICH, A
    ZEITSCHRIFT FUR KARDIOLOGIE, 1994, 83 : 201 - 205
  • [44] Mortality Analysis of Patients Undergoing Lung Transplantation for Emphysema
    Minambres, Eduardo
    Zurbano, Felipe
    Naranjo, Sara
    Llorca, Javier
    Manuel Cifrian, Jose
    Gonzalez-Castro, Alejandro
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (07): : 335 - 340
  • [45] Lung transplantation for idiopathic pulmonary fibrosis
    Le Pavec, Jerome
    Dauriat, Gaelle
    Gazengel, Pierre
    Dolidon, Samuel
    Hanna, Amir
    Feuillet, Severine
    Pradere, Pauline
    Crutu, Adrian
    Florea, Valentina
    Boulate, David
    Mitilian, Delphine
    Fabre, Dominique
    Mussot, Sacha
    Mercier, Olaf
    Fadel, Elie
    PRESSE MEDICALE, 2020, 49 (02):
  • [46] Lung Transplantation for Pulmonary Arterial Hypertension
    Kolaitis, Nicholas A.
    CHEST, 2023, 164 (04) : 992 - 1006
  • [47] Lung transplantation for pediatric pulmonary hypertension
    Hanna, Brian D.
    Conrad, Carol
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2009, 27 (1-2) : 49 - 55
  • [48] Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity
    Michelfelder, M.
    Becker, M.
    Riedlinger, A.
    Siegert, E.
    Droemann, D.
    Yu, X.
    Petersen, F.
    Riemekasten, G.
    CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 381 - 390
  • [49] Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity
    M. Michelfelder
    M. Becker
    A. Riedlinger
    E. Siegert
    D. Drömann
    X. Yu
    F. Petersen
    G. Riemekasten
    Clinical Rheumatology, 2017, 36 : 381 - 390
  • [50] Inhaled areosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation
    Della Rocca, G.
    Coccia, C.
    Pompei, L.
    Costa, M. G.
    Di Marco, P.
    Pietropaoli, P.
    MINERVA ANESTESIOLOGICA, 2008, 74 (11) : 627 - 633